Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurigene Discovery Technologies LimitedfiledCriticalAurigene Discovery Technologies Limited
Publication of HK1226943A1publicationCriticalpatent/HK1226943A1/en
Publication of HK1226943BpublicationCriticalpatent/HK1226943B/en
The present invention relates to cyclic peptidomimetic compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PD1) signalling pathway. The invention also relates to derivatives of the therapeutic agents. The invention also encompasses the use of the said therapeutic agents and derivatives for treatment of disorders via immunopotentiation comprising inhibition of immunosuppressive signal induced due to PD-1, PD-L1, or PD-L2 and therapies using them.
HK17100404.1A2013-09-062014-09-05Cyclic peptidomimetic compounds as immunomodulators
HK1226943B
(en)